NM_000202.8(IDS):c.418+2T>C AND Mucopolysaccharidosis, MPS-II
- Germline classification:
- Pathogenic (3 submissions)
- Last evaluated:
- Jun 7, 2024
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV001568381.4
Allele description [Variation Report for NM_000202.8(IDS):c.418+2T>C]
NM_000202.8(IDS):c.418+2T>C
Condition(s)
- Name:
- Mucopolysaccharidosis, MPS-II (MPS2)
- Synonyms:
- Mucopolysaccharidosis type II; Attenuated MPS (subtype; formerly known as mild MPS II); Severe MPS II; See all synonyms [MedGen]
- Identifiers:
- MONDO: MONDO:0010674; MedGen: C0026705; Orphanet: 580; OMIM: 309900
-
Mus musculus Sad1 and UNC84 domain containing 1 (Sun1), transcript variant 4, mR...
Mus musculus Sad1 and UNC84 domain containing 1 (Sun1), transcript variant 4, mRNAgi|371121163|ref|NM_001256117.1|Nucleotide
-
WP_000695369 (0)
Books
-
PREDICTED: Rattus norvegicus aprataxin (Aptx), transcript variant X4, mRNA
PREDICTED: Rattus norvegicus aprataxin (Aptx), transcript variant X4, mRNAgi|2678942714|ref|XM_006238029.5|Nucleotide
-
Homo sapiens mRNA; cDNA DKFZp564C0464 (from clone DKFZp564C0464)
Homo sapiens mRNA; cDNA DKFZp564C0464 (from clone DKFZp564C0464)gi|12052837|emb|AL136657.1|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Aug 4, 2024